Cytori Technology Selected for NHLBI Funded Trial in LVAD Patients

The Cardiovascular Cell Therapy Research Network , has selected Cytori Therapeutics, Inc. to supply adipose-derived regenerative cells for a clinical trial aimed at evaluating the safety and feasibility of treating patients with Left Ventricular Assist Devices .

http://ift.tt/1sKbZBD